| Name | Title | Contact Details |
|---|
Crypto.com is on a mission to accelerate the world’s transition to cryptocurrency. Through the Crypto.com Mobile App and Exchange, you can buy 150+ cryptocurrencies and stablecoins, such as Bitcoin (BTC), Ethereum (ETH), Cardano (ADA), Solana (SOL) and...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Conga delivers the worlds most scalable revenue lifecycle management solution. Crush complexity. Deliver Certainty.
ADVFN is a UK-based company that provides financial information primarily through the internet, research services, and the development and exploitation of ancillary internet sites. The company offers stocks and shares information website and operates t...
Agora is the materials procurement platform enabling construction subcontractors to automate their procurement process from requisition to delivery.